TREM2 and Alzheimer disease: This report further investigates the role of resveratrol on autophagy via the lysosomal marker cathepsin D and microglial activation via a triggering receptor expressed on myeloid cells (TREM-2), as well as other CSF biomarkers of neuronal and vascular damage in AD patients.